1Rober A,Kitera J,Broteory EG,et al.Clinical correlation between hypercoagulability and thromboetic phenomenon.Thromb Res,1994,74:125-131.
2Levin EG,Naragaj GR,Takiee T,et al.Latent tissue plasminogen activator produced by human endothelial cells in culture:Evidence for an enzymeinhibitor complex.Proc Natl Acad Sci USA,1996,93:6804-6809.
3Kruithof EKO,Gubrabi TD,Hunter I, et al.Demonstration of a fastacting inhibitor of plasminogen activators in human plasma.Blood,1994,84:1907-1911.
4Wimah B,Mecham RP,Mayer V. The role of the fibrinolytic system in deep vein thrombosis.J Lab Clin Med,1995,135:365-372.
5Nilsson IM,Nisch R,Fox JW,et al.Two different mechanisms in patients with venous thrombosis and defective fibrinolysis:Low concentration of plasminogen activator of increased concentration of plasminogen activator inhibitor.Br Med J,1995,310:2053-2065.
6Tomura S,Nakamura Y,Deguchi F,et al.Coagulation and fibrinolysis in patients with chronic renal failure and undergoing conservative treatment.Thromb Res,1991,64:81-89.
7Park K ,Kye C,Lee M,et al.Fibrinolytic activity of the earthworm extract.Thomb Haemost,1989,62(1):689-692.
8Mihara H,Killem PD,Takemura T,et al.Thrombolytic proteases from earthworm.Eur pat Appl,1984,82:92-105.
9Mihara H,Fine LJ,Okuda S,et al.A Possibility of earthworm powder as therapeutic agent for thrombosis.Thromb Haemost,1989,62(1):545-548.
